| 12:15a | KIN : Movers and Shakers | PU |
| 08/19 | BRAINSWAY : wins FDA approval for brain stimulation system | AQ |
| 08/19 | BRAINSWAY : FDA OKs BrainsWay non-invasive device to treat OCD in adults | AQ |
| 08/19 | CANNABICS PHARMACEUTICALS : Eroll develop medical cannabis growing device | AQ |
| 08/19 | ANTHEM : High-dollar medical claims hurt Dayton's budget | AQ |
| 08/19 | FLEX PHARMA INC : DEADLINE TOMORROW: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Flex Pharma, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm | AC |
| 08/19 | BRAINSWAY : Israeli OCD treatment gets FDA green light for US marketing | AQ |
| 08/19 | QUEST DIAGNOSTICS : SC mother sues genetics lab after son's death for allegedly misidentifying his condition | AQ |
| 08/19 | LOOK : Two people seriously injured in KZN car crash | AQ |
| 08/19 | ALEXANDRIA PHARMA & CHEMICAL INDUSTRIES : Pharmaceuticals (AXPH.CA) Decisions of the Board of Directors' Meeting | AQ |
| 08/19 | AETNA : Lab billing fraud alleged at rural Oklahoma hospital | AQ |
| 08/18 | VALUE ADDED TECHNOLOGY : 8-18-18 Knoxville Livestock | AQ |
| 08/18 | STRYKER : MILITARY $8,761 Federal Contract Awarded to Stryker | AQ |
| 08/18 | ACHILLION PHARMACEUTICALS : Expands Management Team With Appointment of Anthony S. Gibney as Chief Business Officer | AQ |
| 08/18 | RMTI LOSS NOTICE : Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Rockwell Medical, Inc. - RMTI | PR |
| 08/18 | PFIZER : Regeneron/Teva pain drug fasinumab on target in phase 3 | AQ |
| 08/18 | MERCK AND : Healthy Interactions and Merck Announce Launch of Digital Health Platform Designed to Enhance Patient Engagement in Diabetes Management | AQ |
| 08/18 | CATALENT : acquires Juniper Pharmaceuticals | AQ |
| 08/18 | SAMSUNG BIOLOGICS : looks to expand CDMO biz with $22bn investment | AQ |
| 08/18 | NEUROCRINE BIOSCIENCES : to Present Data on INGREZZA (valbenazine) and Opicapone at the 2018 World Congress on Parkinson`s Disease and Related Disorders | AQ |
| 08/18 | REGENERON PHARMACEUTICALS : sees rejection one day, US FDA approval the next | AQ |
| 08/18 | MOTIF BIO : to Present Iclaprim Data at ESCMID/ASM Conference | AQ |
| 08/18 | NOVO NORDISK A/S : spends $800m to buy biotech and `glucose responsive insulin` tech | AQ |
| 08/18 | Sen. Grassley Requests FTC Assessment of Pharmaceutical Supply Chain Intermediaries and Recent Consolidation | AQ |
| 08/18 | NOVO NORDISK A/S : Acquires Ziylo to Accelerate Its Development of Glucose Responsive Insulins | AQ |
| 08/18 | AERIE PHARMACEUTICALS : Reports Positive Study Results for Eye Pressure Drug Rhopressa | AQ |
| 08/18 | BRAINSWAY : FDA Permits Marketing of Transcranial Magnetic Stimulation for Treatment of Obsessive Compulsive Disorder | AQ |
| 08/18 | NIBEC : claims stable growth despite loss in Q2 | AQ |
| 08/18 | PFIZER : As EpiPens run short, Kalo boasts it has an available supply of epinephrine injectors | AQ |
| 08/18 | GOLDEN LEAF : Announces Acquisition of Combined Cultivation, Production and Retail License in California | AQ |
| 08/18 | MATEON THERAPEUTICS : Receives Notice of Partial Clinical Hold for OX1222 Study | AQ |
| 08/18 | PROMIS NEUROSCIENCES : has 79 per cent upside, says Mackie Research | AQ |
| 08/18 | VERTEX PHARMACEUTICALS : KALYDECO approved as first CF drug in children under 24 months | AQ |
| 08/18 | BIOSIG TECHNOLOGIES : Closes Private Placement | AQ |
| 08/18 | ULTRAGENYX PHARMACEUTICAL : $250,000 Federal Contract Awarded to Ultragenyx Pharmaceutical | AQ |
| 08/18 | MERCK AND : Judicial Panel on Multidistrict Litigation Issues Order on Zostavax | AQ |
| 08/18 | RETROPHIN : 'Pharma Bro' lawyer and partner in crime sentenced to 18 months in jail | AQ |
| 08/18 | ARCH THERAPEUTICS : MetroWest Business Digest for Aug. 18, 2018 | AQ |
| 08/18 | BOSTON SCIENTIFIC : Medtronic testing defibrillator that uses wires outside the heart, veins | AQ |
| 08/18 | APOLLO HOSPITALS : AI-powered platform to predict risk of cardio-vascular disease | AQ |
| 08/18 | OPHTHALMOLOGY DEVICES MARKET : Global Product Intelligence, Analysis, Opportunities and Forecast to 2024: Some of the prominent participants in the Global Ophthalmology Devices Market are Carl Zeiss Meditec AG, Abbott Medical Optics, Inc., Bausch & Lomb, Inc., Alcon, Inc., Haag-Streit, Johnson & Johnson, Essilor International S.A, Nidek Co. Ltd, and Topcon Corporation. | AQ |
| 08/18 | NOTICE TO THE MARKET : Conclusion of a Built to Suit Contract for the Construction of a New Central Lab and others | PU |
| 08/17 | LEAD PLAINTIFF DEADLINE ALERT : Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In ACADIA Pharmaceuticals, Inc. To Contact The Firm | PR |
| 08/17 | Coherus BioSciences Announces New Employment Inducement Grants | GL |
| 08/17 | AVEO PHARMACEUTICALS INC : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K) | AQ |
| 08/17 | CATALYST PHARMACEUTICALS, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K) | AQ |
| 08/17 | THERAPEUTIC INTERNATIONAL : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q) | AQ |
| 08/17 | Sientra Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | GL |
| 08/17 | KALYTERA THERAPEUTICS : Announces Further Payments in Shares under Payments Agreements with Salzman Group | AQ |
| 08/17 | ORASURE TECHNOLOGIES INC : Change in Directors or Principal Officers (form 8-K) | AQ |
United Kingdom
France
Deutschland
Schweiz (DE)
